Home › Funds › EcoR1 Capital, LLC › ATRA

EcoR1 Capital, LLC position in ATRA

ATARA BIOTHERAPEUTICS INC · Health Care

EcoR1 Capital, LLC reported holding 1,552,000 shares of ATRA (ATARA BIOTHERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$17.8M, representing 0.91% of its reported portfolio and ranking #17 among its reported holdings. EcoR1 Capital, LLC has disclosed ATRA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)1.55M sh
Reported value held$17.82M
Portfolio Weight0.91%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How EcoR1 Capital, LLC's ATRA position evolved

EcoR1 Capital, LLC first disclosed a stake in ATRA in Q4 2023 at 10,067,043 shares (US$5.2M). The position peaked in Q2 2026 at 1,552,000 shares, worth US$17.8M. Across 11 filings, EcoR1 Capital, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,552,000 shares valued at US$17.8M — an increase of 1,452,407 shares quarter over quarter.. Notable position changes include a 96% trim in Q2 2024 (shares fell 4% over the following quarter), a 83% trim in Q1 2026 (shares rose 143% over the following quarter), a 1458% increase in Q2 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 10.07M $5.16M New
Q1 2024 10.17M $7.06M Add
Q2 2024 406.68K $3.46M Reduce
Q3 2024 468.94K $3.81M Add
Q4 2024 532.13K $7.08M Add
Q1 2025 573.18K $3.40M Add
Q2 2025 573.18K $4.42M Hold
Q3 2025 573.18K $8.21M Hold
Q4 2025 573.18K $10.37M Hold
Q1 2026 99.59K $471.07K Reduce
Q2 2026 1.55M $17.82M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ATRA and 13F data

ATRA (ATARA BIOTHERAPEUTICS INC) is a Health Care company. 12 other funds we track also report a position in ATRA — the largest reported positions include Redmile Group, LLC (US$5.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ATRA

All ATRA fund holders →

FAQ

How long has EcoR1 Capital, LLC held ATRA?

EcoR1 Capital, LLC has disclosed ATRA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is EcoR1 Capital, LLC's current position in ATRA?

As of Q2 2026, EcoR1 Capital, LLC holds 1.55M shares of ATRA (ATARA BIOTHERAPEUTICS INC), valued at $17.82M, representing 0.91% of its reported portfolio and ranking #17.

Has EcoR1 Capital, LLC been buying or selling ATRA?

In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC increased its position in ATRA. The position peaked in Q2 2026 at 1.55M shares.

Which other funds hold ATRA?

Other major institutional holders of ATRA include Redmile Group, LLC, among 12 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.